Vulvovaginitis
Enviado por Yubarta • 6 de Septiembre de 2011 • 6.806 Palabras (28 Páginas) • 425 Visitas
VULVOVAGINITIS
Background
Vulvovaginitis is the most common gynecologic condition seen by practitioners rendering primary care to women. The term vulvovaginitis is a semantic compromise that categorizes many vaginal infections as vulvovaginitis because the 2 are interrelated. Discharge, burning, and pruritus are the most common symptoms, accompanied by signs of vulvar irritation such as erythema and excoriation of the vulvar skin.
Traditionally, the 3 classic entities of vaginitis include bacterial vaginosis, Trichomonas infection, and candidiasis. However, this article focuses on topics that are primarily inflammatory disorders and affect the vulvar region.
Pathophysiology
The vulva, the external genitalia of the female, includes the labia majora and minora, the clitoris, and the vestibule of the vagina. During the reproductive years of a healthy woman's life, the vagina maintains a moist environment that is in constant fluctuation. The secretion of an alkaline transudate from the vaginal epithelium and cervical glands maintains this moist environment with a pH ranging from 3.8-4.5. In addition, the vagina and its microflora form a unique balanced environment that can change under pressure from external stimuli but returns to normal with removal of the stimuli. It can vary in degree during the menstrual cycle, pregnancy, and sexual activity.
The vaginal epithelium consists of 3 cell layers: superficial, intermediate, and basal. These cells are capable of storing glycogen under the influence of estrogen. Glycogen is available in the fully mature cells in the superficial layer of the epithelium. With elevated levels of either exogenous or endogenous estrogen, all levels of the epithelium thicken as a result of glycogen storage. With diminishing levels of estrogen, the layers become thin and atrophic.
In an adult woman's reproductive years, the bacterial flora of the healthy vagina contains numerous microorganisms, including aerobic and anaerobic gram-positive and gram-negative bacteria. Lactobacillus and Corynebacterium predominate over other bacteria such as Streptococcus, Bacteroides, Staphylococcus, and Peptostreptococcus. Both Lactobacillus and Corynebacterium produce lactic and acetic acid from glycogen, thus maintaining the low vaginal pH. Additional bacteria are kept in check by the acid-producing bacteria and are rarely pathogenic, but they may become pathogenic if the environmental balance is affected.
The skin of the vulva is sensitive to the vaginal environment and hormonal, metabolic, and allergic influences. It is composed of stratified squamous epithelium that contains hair follicles, sebaceous sweat glands, and apocrine glands.
Differential Diagnosis
The focus of this article includes Candida vulvovaginitis, atrophic vaginitis, contact dermatitis, pediatric vulvovaginitis, and vulvar vestibulitis.
The complete differential includes the following:
• Allergic reaction
• Physiologic leukorrhea
• Atopic dermatitis
• Lichen simplex chronicus
• Lichen sclerosus
• Paget disease
• Psoriasis
• Vulvodynia
In prepubertal girls with vaginal discharge, the following should be considered:
• Anatomic abnormality
• Foreign bodies
• Neoplasm
• Sexual abuse
• Hygiene
Vulvovaginal Candidiasis
In the United States, estimates indicate that approximately 50% of college-aged women will have an episode of vulvovaginal candidiasis. At some point in their lifetime, nearly 75% of all women experience an attack of Candida vulvovaginitis. Approximately half of these women have more than 1 episode, and a few have frequent relapses.
Etiology
Vulvovaginal candidiasis can be an acute, chronic, recurrent, or persistent condition that can involve the vulva, vagina, and adjacent crural areas. The specific causative agent belongs to the genus Candida. These organisms are found in almost all humans and many animals. An estimated 10-50% of reproductive-aged American women are considered opportunistic carriers. Candida albicans is identified approximately 85-90% of the time. Recently, an increased frequency of other Candida species, such as Candida glabrata, Candida tropicalis, and Candida krusei, has been reported. The emergence of these other Candida species may possibly be due to widespread use of over-the-counter drugs, long-term use of suppressive azoles, and the use of frequent short courses of antifungal drugs.
Predisposing agents
Any host factor that affects the vaginal environment or vaginal secretions can play a role in the initiation of Candida vulvovaginitis. Pregnancy is one of the most common predisposing factors. Studies have demonstrated that up to one third of pregnant women worldwide on any day can be affected. The high levels of reproductive hormones and an increase in the glycogen content in the vaginal environment create a favorable environment for Candida species. In combination, these 2 changes provide an abundant source of carbon for candidal growth, germination, and adherence. Furthermore, the acidity of the pregnant vaginal flora can suppress the growth of other microorganisms that are naturally inhibitory to Candida. Although the initial attachment of the organism occurs more readily at high pH values (6-7), the germ tube formation and the development of mycelia are favored by a low vaginal pH (< 5).
Older studies of women using high-dose estrogens in oral contraceptives found an increase in vaginal colonization by Candida. The mechanism is believed to be similar to that found in pregnancy. However, the newer oral contraceptives with a lower estrogen dose do not seem to predispose the patient to Candida vulvovaginitis.
Disorders associated with an altered immune response, such as acquired immunodeficiency syndrome (AIDS) and diabetes mellitus, also predispose to Candida vulvovaginitis.
Antimicrobials are thought to predispose a patient to Candida by reducing the number of protective resident vaginal bacteria. The most common offenders are broad-spectrum agents such as tetracycline, cephalosporins, and ampicillin-like agents.
A study by Horowitz et al in 1987 demonstrated Candida species in ejaculate fluid of partners of patients with recurrent Candida infections. They suggested that the carrier rate might be low.[1] Traditionally, vulvovaginal candidiasis is not considered a sexually transmitted disease because it occurs in celibate women, and Candida itself is considered part of the normal vaginal flora.
Clinical
In acute vulvovaginal candidiasis, vulvar pruritus and burning are the main symptoms. Patients commonly complain of both symptoms after intercourse or upon urination. Dyspareunia may develop
...